HER2+ Horizons

Sara Tolaney, MD, MPHHER2 Breast Cancer | July 14, 2025
Dr. Sara Tolaney explores how DESTINY-Breast09 may reshape first-line treatment in HER2+ metastatic breast cancer.
Listen Now
Latest News
August 13, 2025